MichaelAGelfandMD

Neurology • Philadelphia, PA

Epilepsy, Neurophysiology

Physician

Join to view full profile

Dr. Gelfand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gelfand's full profile

Already have an account?

Office
3400 Civic Center Blvd
# 2
Philadelphia, PA 19104
Phone+1 215-662-3606

Education & Training

University of Pennsylvania Health SystemFellowship, Epilepsy, 2014 - 2015
University of Pennsylvania Health SystemResidency, Neurology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2010 - 2011
Weill Cornell MedicineClass of 2010

Certifications & Licensure

PA State Medical License 2011 - 2024
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Epilepsy

Clinical Trials

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Start of enrollment: 2020 Jan 27
Active, not recruiting
Phase 2
Roles: Contact
A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Start of enrollment: 2020 Jan 27
Active, not recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

Clinical characteristics and surgical outcomes of epilepsy associated with temporal encephalocele: A systematic review.
Daniel J Zhou, Sarah Woodson-Smith, Brian E Emmert, Alana Kornspun, Joshua Larocque
Epilepsy & Behavior. 2024-09-01
Thinking Three-Dimensionally: A Self- and Externally-Controlled Approach to Screening for Drug-Drug-Drug Interactions Among High-Risk Populations.
Emily K Acton, Sean Hennessy, Michael A Gelfand, Charles E Leonard, Warren B Bilker
Clinical Pharmacology and Therapeutics. 2024-08-01
3 citations
Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events.
Emily K Acton, Sean Hennessy, Michael A Gelfand, Charles E Leonard, Warren B Bilker
JAMA Neurology. 2024-08-01